The Newsroom

Investigations  /  08.21.2014

Cytori Therapeutics, Inc.

Robbins Arroyo LLP Is Investigating the Officers and Directors of Cytori Therapeutics, Inc. (CYTX) on Behalf of Shareholders

Robbins Arroyo LLP is investigating whether certain officers and directors of Cytori Therapeutics, Inc. (NASDAQ: CYTX) breached their fiduciary duties to shareholders. Cytori is a cell therapy company that develops cell therapies based on autologous adipose-deprived regenerative cells to treat cardiovascular disease and other medical conditions.

Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, or you can complete the form below and we will contact you directly.

Shareholder Information

  • Please Note: Neither the submission to nor the receipt of information by Robbins Arroyo LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

Please Note: Neither the submission to nor the receipt of information by Robbins Arroyo LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

How can we help you?

CONTACT US TODAY | 1-800-350-6003 or info@robbinsarroyo.com

Tell us your concerns